Clinicopathologic and Molecular Study of TFEB-altered Renal Cell Carcinomas

TFEB 生物 病理 癌症研究 医学 遗传学 基因 生物发生
作者
Mengxin Zhang,Jie Xian,Jiaxiang Tang,Ying Nan Yang,Jue Hu,Xiuyi Pan,Linmao Zheng,Yifan Kang,Mengni Zhang,Xuejiao Yu,Xueqin Chen,Ling Nie,Hao Zeng,Qiao Zhou,Ni Chen
出处
期刊:The American Journal of Surgical Pathology [Lippincott Williams & Wilkins]
卷期号:50 (1): 84-102 被引量:11
标识
DOI:10.1097/pas.0000000000002458
摘要

TFEB -altered renal cell carcinoma (RCC) included TFEB -rearranged and TFEB -amplified RCC with unclear clinicopathological features and treatment options. Cases of TFEB -altered RCCs were collected. Fourteen cases showed TFEB rearrangement. Five MALAT1::TFEB fusions and one ACTB::TFEB fusion were verified. 8/14 TFEB -rearranged RCCs showed biphasic "pseudorosette" structure. All TFEB -rearranged RCC patients were alive without recurrence or metastasis after 3 to 122 months. Fifteen cases showed TFEB amplification, including 5 high-level amplifications (>10 copies) and ten low-level amplifications (5 to 10 copies), including 3 cases showing concomitant TFEB amplification and rearrangement. TFEB -amplified RCCs were high-grade, showing papillary, solid, nested, or alveolar arrangements of cells. In addition, 8 cases showed 3 to 4 TFEB signals were collected, indicating diverse morphologies. PDL1 membranous staining was observed in 9/10 TFEB -rearranged RCCs, and 11/13 TFEB -amplified RCCs. Copy number variation analysis revealed specific amplification of chromosome 6p21.1, where TFEB, VEGFA6 , and CCND3 were located, in one high- and 2 low-level amplification cases. Four cases with 3 to 4 TFEB signals did not show specific amplification of this region. Within the follow-up periods of 3 to 64 months, 8/13 TFEB -amplified RCC cases presented with metastasis, and 3/13 patients died in the 12th and 24th months. The treatment processes in several cases and the detailed therapeutic course of a TFEB -amplified case were documented, highlighting the efficacy of PD-1 inhibitors. Our research supported a cutoff of ≥5 TFEB copies for the diagnosis of TFEB -amplified RCCs, though further studies were needed regarding the threshold. The expression of PDL1 might indicate a potential benefit of PD-1 inhibitors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
可靠松思完成签到,获得积分10
刚刚
刚刚
刚刚
舒心莫言完成签到,获得积分10
刚刚
罗亚亚完成签到,获得积分10
1秒前
方圆几里完成签到,获得积分10
1秒前
alee完成签到,获得积分10
1秒前
意义完成签到,获得积分10
1秒前
强健的海菡完成签到 ,获得积分10
1秒前
369ninja发布了新的文献求助10
1秒前
小雨关注了科研通微信公众号
1秒前
zhangyupei的应助被大胆凡白采纳,获得10
1秒前
brynn发布了新的文献求助10
2秒前
wwwwwww完成签到,获得积分10
2秒前
2秒前
3秒前
许诺一世繁华完成签到 ,获得积分10
3秒前
科研通AI2S的应助被123采纳,获得10
3秒前
jjffyy完成签到,获得积分10
3秒前
4秒前
4秒前
4秒前
慕青的应助被lancerimpp采纳,获得10
4秒前
Wray完成签到,获得积分10
4秒前
轻松的雨旋完成签到,获得积分10
4秒前
Guavazeal发布了新的文献求助10
4秒前
赘婿的应助被终有花开日采纳,获得10
4秒前
wzy发布了新的文献求助10
5秒前
5秒前
zzfplay完成签到,获得积分10
5秒前
5秒前
苦哈哈完成签到,获得积分10
5秒前
嘉浩完成签到,获得积分10
6秒前
kay发布了新的文献求助10
6秒前
Hayden完成签到,获得积分10
6秒前
FashionBoy的应助被yj采纳,获得10
6秒前
xifala完成签到,获得积分10
6秒前
zhangjoy完成签到,获得积分10
6秒前
6秒前
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180757
求助须知:如何正确求助?哪些是违规求助? 9570857
关于积分的说明 21814590
捐赠科研通 7777053
什么是DOI,文献DOI怎么找? 3433314
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479315